411 related articles for article (PubMed ID: 25704387)
1. F-18 fluoromisonidazole for imaging tumor hypoxia: imaging the microenvironment for personalized cancer therapy.
Rajendran JG; Krohn KA
Semin Nucl Med; 2015 Mar; 45(2):151-62. PubMed ID: 25704387
[TBL] [Abstract][Full Text] [Related]
2. Imaging hypoxia and angiogenesis in tumors.
Rajendran JG; Krohn KA
Radiol Clin North Am; 2005 Jan; 43(1):169-87. PubMed ID: 15693655
[TBL] [Abstract][Full Text] [Related]
3. High reproducibility of tumor hypoxia evaluated by 18F-fluoromisonidazole PET for head and neck cancer.
Okamoto S; Shiga T; Yasuda K; Ito YM; Magota K; Kasai K; Kuge Y; Shirato H; Tamaki N
J Nucl Med; 2013 Feb; 54(2):201-7. PubMed ID: 23321456
[TBL] [Abstract][Full Text] [Related]
4. Lack of correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in non-small cell lung cancer assessed by 18F-Fluoromisonidazole and 18F-FDG PET.
Cherk MH; Foo SS; Poon AM; Knight SR; Murone C; Papenfuss AT; Sachinidis JI; Saunder TH; O'Keefe GJ; Scott AM
J Nucl Med; 2006 Dec; 47(12):1921-6. PubMed ID: 17138734
[TBL] [Abstract][Full Text] [Related]
5. Correlation between tumor oxygenation and 18F-fluoromisonidazole PET data simulated based on microvessel images.
Mönnich D; Troost EG; Kaanders JH; Oyen WJ; Alber M; Zips D; Thorwarth D
Acta Oncol; 2013 Oct; 52(7):1308-13. PubMed ID: 23984808
[TBL] [Abstract][Full Text] [Related]
6. [
McNeal KC; Reeves KM; Song PN; Lapi SE; Sorace AG; Larimer BM
Nucl Med Biol; 2024; 134-135():108918. PubMed ID: 38772123
[TBL] [Abstract][Full Text] [Related]
7. Hypoxia and tumor metabolism in radiation oncology: targets visualized by positron emission tomography.
Wijsman R; Kaanders JH; Oyen WJ; Bussink J
Q J Nucl Med Mol Imaging; 2013 Sep; 57(3):244-56. PubMed ID: 24045621
[TBL] [Abstract][Full Text] [Related]
8. Assessment of hypoxia and perfusion in human brain tumors using PET with 18F-fluoromisonidazole and 15O-H2O.
Bruehlmeier M; Roelcke U; Schubiger PA; Ametamey SM
J Nucl Med; 2004 Nov; 45(11):1851-9. PubMed ID: 15534054
[TBL] [Abstract][Full Text] [Related]
9. Molecular Imaging of Tumor Hypoxia: Existing Problems and Their Potential Model-Based Solutions.
Shi K; Ziegler SI; Vaupel P
Adv Exp Med Biol; 2016; 923():87-93. PubMed ID: 27526129
[TBL] [Abstract][Full Text] [Related]
10. Hypoxia-specific tumor imaging with 18F-fluoroazomycin arabinoside.
Piert M; Machulla HJ; Picchio M; Reischl G; Ziegler S; Kumar P; Wester HJ; Beck R; McEwan AJ; Wiebe LI; Schwaiger M
J Nucl Med; 2005 Jan; 46(1):106-13. PubMed ID: 15632040
[TBL] [Abstract][Full Text] [Related]
11. [Accumulation Mechanism of 2-Nitroimidazole-based Hypoxia Imaging Probes Revealed by Imaging Mass Spectrometry].
Shimizu Y
Yakugaku Zasshi; 2018; 138(11):1345-1352. PubMed ID: 30381642
[TBL] [Abstract][Full Text] [Related]
12. Correlation of hypoxic cell fraction and angiogenesis with glucose metabolic rate in gliomas using 18F-fluoromisonidazole, 18F-FDG PET, and immunohistochemical studies.
Cher LM; Murone C; Lawrentschuk N; Ramdave S; Papenfuss A; Hannah A; O'Keefe GJ; Sachinidis JI; Berlangieri SU; Fabinyi G; Scott AM
J Nucl Med; 2006 Mar; 47(3):410-8. PubMed ID: 16513609
[TBL] [Abstract][Full Text] [Related]
13. Correlation of (18)F-fluoromisonidazole PET findings with HIF-1α and p53 expressions in head and neck cancer: comparison with (18)F-FDG PET.
Norikane T; Yamamoto Y; Maeda Y; Kudomi N; Matsunaga T; Haba R; Iwasaki A; Hoshikawa H; Nishiyama Y
Nucl Med Commun; 2014 Jan; 35(1):30-5. PubMed ID: 24121312
[TBL] [Abstract][Full Text] [Related]
14. ¹⁸F-HX4 hypoxia imaging with PET/CT in head and neck cancer: a comparison with ¹⁸F-FMISO.
Chen L; Zhang Z; Kolb HC; Walsh JC; Zhang J; Guan Y
Nucl Med Commun; 2012 Oct; 33(10):1096-102. PubMed ID: 22836736
[TBL] [Abstract][Full Text] [Related]
15. A patient-specific computational model of hypoxia-modulated radiation resistance in glioblastoma using 18F-FMISO-PET.
Rockne RC; Trister AD; Jacobs J; Hawkins-Daarud AJ; Neal ML; Hendrickson K; Mrugala MM; Rockhill JK; Kinahan P; Krohn KA; Swanson KR
J R Soc Interface; 2015 Feb; 12(103):. PubMed ID: 25540239
[TBL] [Abstract][Full Text] [Related]
16. Assessment of regional tumor hypoxia using 18F-fluoromisonidazole and 64Cu(II)-diacetyl-bis(N4-methylthiosemicarbazone) positron emission tomography: Comparative study featuring microPET imaging, Po2 probe measurement, autoradiography, and fluorescent microscopy in the R3327-AT and FaDu rat tumor models.
O'Donoghue JA; Zanzonico P; Pugachev A; Wen B; Smith-Jones P; Cai S; Burnazi E; Finn RD; Burgman P; Ruan S; Lewis JS; Welch MJ; Ling CC; Humm JL
Int J Radiat Oncol Biol Phys; 2005 Apr; 61(5):1493-502. PubMed ID: 15817355
[TBL] [Abstract][Full Text] [Related]
17. 18F-fluoromisonidazole PET uptake is correlated with hypoxia-inducible factor-1α expression in oral squamous cell carcinoma.
Sato J; Kitagawa Y; Yamazaki Y; Hata H; Okamoto S; Shiga T; Shindoh M; Kuge Y; Tamaki N
J Nucl Med; 2013 Jul; 54(7):1060-5. PubMed ID: 23699668
[TBL] [Abstract][Full Text] [Related]
18. Imaging hypoxia after oxygenation-modification: comparing [18F]FMISO autoradiography with pimonidazole immunohistochemistry in human xenograft tumors.
Troost EG; Laverman P; Kaanders JH; Philippens M; Lok J; Oyen WJ; van der Kogel AJ; Boerman OC; Bussink J
Radiother Oncol; 2006 Aug; 80(2):157-64. PubMed ID: 16905213
[TBL] [Abstract][Full Text] [Related]
19. Identifying hypoxia in human tumors: A correlation study between 18F-FMISO PET and the Eppendorf oxygen-sensitive electrode.
Mortensen LS; Buus S; Nordsmark M; Bentzen L; Munk OL; Keiding S; Overgaard J
Acta Oncol; 2010 Oct; 49(7):934-40. PubMed ID: 20831480
[TBL] [Abstract][Full Text] [Related]
20. Hypoxia imaging in gliomas with 18F-fluoromisonidazole PET: toward clinical translation.
Bell C; Dowson N; Fay M; Thomas P; Puttick S; Gal Y; Rose S
Semin Nucl Med; 2015 Mar; 45(2):136-50. PubMed ID: 25704386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
